Antiepileptic drugs in the treatment of neuropathic pain

References

• McDonald RL. Cellular effects of anti- epileptic drugs. In: Epilepsy: a comprehensive Textbook, Engel J, Pedley TA. (eds.), Lippincott-Rven Publishers, Philadelphia, pp. 1383–1391 (1997).
   Google Scholar
• Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 73,123–140 (1997).
   PubMed Web of Science ®Google Scholar
• •Review on the treatment of neuropathic pain including AEDs.
   Google Scholar
• McQuay H, Carroll D, Jadad AR, Wiffern P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ311,1047–1055 (1995).
   PubMed Web of Science ®Google Scholar
• •Review on AEDs in the treatment of pain.
   Google Scholar
• Magnus L. Nonepileptic uses of gabapentin. Epilepsia 40\(Suppl. 6), S66—S72 (1999).
   Google Scholar
• •Review on AEDs in the treatment of pain.
   Google Scholar
• Tremont-Lukats IW Megeff C, Backonja M1N4. Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. DITIF 60,1029–1052 (2000).
   Google Scholar
• •Review on AEDs in the treatment of pain.
   Google Scholar
• Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms and management. Lancet 35,1959–1964 (1999).
   Google Scholar
• •Review on the treatment of neuropathic pain including AEDs.
   Google Scholar
• Attal N, Bouhassira D. Overview of the mechanisms of neuropathic pain. Acta Neural. Scand. 173(Suppl.), 12–24 (1999).
   Google Scholar
• Cummings TR and Waxman SG. Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury.' Newtsci. 17,3503–3514 (1997).
   Google Scholar
• Kral MG, Xiong Z, Study RE. Alteration of No+ currents in dorsal root ganglion neurons from rats with a painful neuropathy. Pain 81, 15–24 (1999).
   Google Scholar
• Price DD, Mao J, Mayer D. Central mechanism of normal and abnormal pain states. In: Progress in Pain Researrh and Management, Fields HL, Liebeskind JC (Eds.), IASP Press, Seattle, USA vol.1, 61–84 (1994).
   Google Scholar
• Ibuki T, Hama AT, Wang XT, Pappas GD, Sagen J. Loss of GABA immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts. Neurosci 96,845–858 (1997).
   Google Scholar
• Attal N. Chronic neuropathic pain: mechanisms and treatment. an. j Pain 16, S118—S131 (2000).
   Web of Science ®Google Scholar
• •Review on the treatment of neuropathic pain including AEDs.
   Google Scholar
• Sindrup SH, Jensen TS. Efficacy of pharmacological treatment of neuropathic pain: an update and effect related to mechanism of drug action. Pain 81,389–400 (1999).
   Google Scholar
• •Review on the treatment of neuropathic pain including AEDs.
   Google Scholar
• Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology55, 915–920 (2000).
   PubMed Web of Science ®Google Scholar
• •Review on the treatment of neuropathic pain including AEDs.
   Google Scholar
• Brau ME, Dreimann M, Olschewski A, Vogel W, Hempelmann G Effects of drugs used for neuropathic pain management on tetrodotoxin-resistant No+ currrents in rat sensory neurons. Anesthesia 94,137–144 (2001).
   Google Scholar
• Kuo CC. A common anticonvulsant binding site for phenytoin, carbamazepine and lamotrigine in neuronal Na+ channels. Molecular Pharmacol 54,712–721 (1998).
   PubMed Web of Science ®Google Scholar
• Fariello RG. Valproic acid : mechanisms of action. In: Anti-epileptic drugs.Levy RH, Mattson RII, Melderum BS (Eds.),Raven Press, New York, USA 581–588 (1995).
   Google Scholar
• Teoh H, Fowler LJ, Bowery NG. Effect of lamotrigine on the electrically-evoked release of endogenous amino acids from slides of dorsal horn of the rat spinal cord. Neuropharmacol 34,1273–1278 (1995).
   Google Scholar
• Stefani A, Spadoni F, Berdnardi G. Voltage- activated calcium channels : targets of anti-epileptic drug therapy? Epilepsia 38,959–965 (1997).
   Google Scholar
• Grunze H, von Wegerer J, Greene RVV, Walden J. Modulation of calcium and potassium currents by lamotrigine. Neuropsychobiol 38,131–138 (1998).
   PubMed Web of Science ®Google Scholar
• Chapman V, Wildman MA, Dickenson AH. Distinct electrophysiological effects of two spinally administered membrane stabilizing drugs, bupivacane and lamotrigine. Pain 71,285–295 (1997).
   Google Scholar
• Taverna S, Sancini G, Mantegazza M, Franceschetti S, Avanzini G. Inhibition of transient and persisten Na+ current fractions by the new anticonvulsant topiramate. j Pharmacol Exp. Ther. 288, 960–968 (1999).
   Google Scholar
• White S. Clinical significance of animal seizure models and mechanisms of action studies of potential anti-epileptic drugs. Epilepsia 38, S9—S17 (1997).
   Google Scholar
• Taylor CP, Gee NS, Su TZ et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 29, 233–249 (1998).
   PubMed Web of Science ®Google Scholar
• Petroff OA, Hyder F, Rothman DL, Mattson RII. Effects of gabapentin onbrain GABA, homocarnosine and pyrrolidinone in epilepsy patients. Epilepsia 41,675–680 (2000).
   PubMed Web of Science ®Google Scholar
• Hwang JHH, Yaksh TL. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg. Anesth. 22,249–256 (1997).
   PubMedGoogle Scholar
• Gee NS, Brown JP, Dissanayake VUK, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the a28 subunit of a calcium channel. Bid Chem. 271,5768-
   Google Scholar
• Luo ZD, Chaplan SR, Higuera ES et al. Upregulation of dorsal root ganglion (alpha)2 (delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J. Neurosci. 21,1868-1875 (2001).
   Google Scholar
• Stefani A, Spadoni F, Giacomini P, Lavaroni F, Bernardi G. The effects of gabapentin on different ligand- and voltage-gated currents in isolated cortical neurons. Epilepsy Res. 43,239–248 (2001).
   Google Scholar
• Pan HL, Eisenach JC, Chen SR. Gabapentin suppresses ectopic discharges and reverses allodynia in neuropathic rats. J. Pharmacol Exp. Ther 288,1026–1030 (1999).
   Google Scholar
• Abdi S, Hyun D, Chung JM. The anti- allodynic effects of amitriptyline, gabapentin and lidocaine in a rat model of neuropathic pain. Anesth. Analg: 87,1360-1366 (1998).
   Google Scholar
• Leach JP, Sills GJ, Majid A et al Effects of tiagabine and vigabatrin on GABA uptake into primary cultures of rat cortical astrocytes. Seizure 5,229–234 (1996).
   PubMed Web of Science ®Google Scholar
• Ipponi A, Lamberti C, Medica A, Bartoli A, Malmberg-Aiello P. Tagabine antinociception in rodents depends on GABA(B) receptor activation : parallel antinociception testing and medial thalamus GABA microdyalisis. Eur Pharmacol 368,205–211 (1999).
   PubMedGoogle Scholar
• Giardina WJ, Decker MW, Porsolt RD et al. An evaluation of the GABA uptacke blocker tiagabine in animal models of neuropathic and nocciceptive pain. Drug-Develop. Res. 44,106–113 (1998).
   Web of Science ®Google Scholar
• Hunter JC, Gogas KR, Hedley LR et al. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur j Pharmacol 324,153–160 (1997).
   PubMed Web of Science ®Google Scholar
• Idanpaan-Heikkila JJ, Guilbaud G. Pharmacological studies on a rat model of trigeminal neuropathic pain : baclofen but not carbamazepine, morphine or tricyclic antidepressants, attenuates the allodynia-like behaviour. Pain 79,281–290 (1999).
   PubMed Web of Science ®Google Scholar
• Nakamura-Craig M, Follenfant RL. Effect of lamotrigine in the acute and chronic hyperalgesia induced by PGE2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetes. Pain 63, 33–37 (1995).
   Google Scholar
• Field MJ, McCleary S, Hughes J, Singh L. Gabapentin and pregabalin but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozotocin in the rat. Pain 80,391–398 (1999).
   PubMed Web of Science ®Google Scholar
• Field MJ, Oles RJ, Lewis AS, McCleary S, Hughes J, Singh L. Gabapentin (neurontin) and 5- (+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br. J. Pharmacol 121,1513–1522 (1997).
   Google Scholar
• Bergouignan M. Cures heureuses de nevralgies faciales essentielles par le diphenylhydantoinate de soude. Rev Laryngol Oto. Rhino]: (arleaux) 63,34–41 (1942).
   Google Scholar
• Blom S. Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G32883). Lancetl, 839–840 (1962).
   Google Scholar
• Ellenberg M. Treatment of diabetic neuropathy with diphenylhydantoïn. New York State NkcI68, 2653 (1968).
   PubMedGoogle Scholar
• Rull JA, Quibera R, Gonzalez-Millan Castaneda OL. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol) : Double-blind Crossover trial. Diabetologia 5,215–218 (1969).
   PubMed Web of Science ®Google Scholar
• Grant SM, Faulds D. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders. Drugs 43,873–888 (1992).
   Google Scholar
• Beydoun A. Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials. Pharmacothempy20, 152S-158S (2000).
   Google Scholar
• Canavero S, Bonicalzi V Lamotrigine control of central pain. Pain 68,179–181 (1996).
   PubMed Web of Science ®Google Scholar
• McCleane GJ. Lamotrigine in the management of neuropathic pain: a review of the literature. Clin. Pain 321–326 (2000).
   Google Scholar
• •Review on AEDs in the treatment of pain.
   Google Scholar
• Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo-controlled crossover trial. Pain 73, 223–230 (1997).
   PubMed Web of Science ®Google Scholar
• •Main RCTs of AEDs in the treatment of neuropathic pain.
   Google Scholar
• Simpson DM, Olney R, McArthur JC, Khan A, Godbold J, Ebel-Frommer K. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neumlogy13(54), 2115–2119 (2000).
   Google Scholar
• •Main RCTs of AEDs in the treatment of neuropathic pain.
   Google Scholar
• Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology56, 184–190 (2001).
   PubMed Web of Science ®Google Scholar
• •Main RCTs of AEDs in the treatment of neuropathic pain.
   Google Scholar
• McCleane GJ. Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study. Anesth. Analg: 89,985–998 (1999).
   PubMed Web of Science ®Google Scholar
• •Main RCTs of AEDs in the treatment of neuropathic pain.
   Google Scholar
• Bijwa ZH, Sarni N, Warfield CA, Wootton J. Topiramate relieves refractory intercostal neuralgia. Neurology 52, 1917 (1999).
   Web of Science ®Google Scholar
• Timberlake C, Chong S, Fung M, Smith T, Hanna M. Topiramate, a novel anti-epileptic drug, in neuropathic pain. Proceedings of the 9th World Congress on Pain (Abstract 210), 65 (1999).
   Google Scholar
• Gilron I, Booher SL, Rowan JS, Max MB. Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study. Clin. Neuropharmacol 24, 109–112 (2001).
   PubMed Web of Science ®Google Scholar
• Solaro C, Messmer Uccelli M, Uccelli A, Leandri M, Mancardi GL. Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur Neural 44, 45–48 (2000).
   PubMed Web of Science ®Google Scholar
• Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L, for the Gabapentin Postherpetic Neuralgia Study Group. Gabapentin in the treatment of postherpetic neuralgia. JAlVIA 280, 1837–1842 (1998).
   Google Scholar
• •Main RCTs of AEDs in the treatment of neuropathic pain.
   Google Scholar
• Backonja M, Beydoyn A, Edwards KR et al, for the Gabapentin Diabetic Neuropathy Study Group. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JA/V/A 280, 1831–1836 (1998).
   Google Scholar
• •Main RCTs of AEDs in the treatment of neuropathic pain.
   Google Scholar
• Morello CM, Leckband SG, Stoner CP, Moorhose DF, Sahagian GA. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch. Intern. Med. 139, 1931–1937 (1999).
   Google Scholar
• McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain 68, 217–227 (1996).
   PubMed Web of Science ®Google Scholar
• Collins SL, Moorre RA, McQuay HJ, Wiffen P Antidepressants and anticonvulsants for diabetic neuropathic and postherpetic neuralgia: a quantitative systematic review. J. Pain Symptom Manage. 20, 449–458 (2000).
   PubMed Web of Science ®Google Scholar
• •Review on AEDs in the treatment of pain.
   Google Scholar
• McCleane GJ. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo-controlled trial. Pain 83, 105–107 (1999).
   PubMed Web of Science ®Google Scholar
• Attal N, Brasseur B, Parker F, Chauvin M, Bouhassira D. Effects of the anticonvulsant gabapentin on peripheral and central neuropathic pain: a pilot study. Eur Neural 40, 191–200 (1998).
   PubMed Web of Science ®Google Scholar
• Eisenberg E, Alon N, Ishay A, Daoud D, Yarnitski D. Lamotrigine in the treatment of painful diabetic neuropathy. Eur Neural 5, 167–173 (1998).
   Google Scholar
• Eckhardt K, Ammon S, Hofmann U, Riebe A, Gugeler N, Mikus G. Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth. Analg: 91, 185–191 (2000).
   PubMed Web of Science ®Google Scholar
• Bialer M, Johannessen SI, Kupferberg HJ, Levy RII, Loiseau P, Perucca E. Progressreport on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V). Epilepsy Res 43, 11–58 (2001).
   PubMed Web of Science ®Google Scholar